MedPath

Efficacy of low-dose hCG adjunct to r-hFSH plus GnRH antagonist for ovarian stimulation in assisted reproductive technology

Phase 2
Conditions
infertility.
Female infertility associated with anovulation
Registration Number
IRCT201211197165N2
Lead Sponsor
Vice Chancellor for Research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

infertile female patient; age between 20-39 years old; body mass index(BMI) of 20- 25 kg/m2; a normal uterus and two functional ovaries; day 3 FSH level< 10 IU/L and E2 level< 60 pg/ml.Exclusion criteria: history of > 2 unsuccessful IVF/ICSI attempts; poor ovarian response in previous IVF/ICSI treatment and any endocrine disorders.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Beta-hCG level. Timepoint: 15 days after oocyte retrieval. Method of measurement: By laboratory kit from blood sample.
Secondary Outcome Measures
NameTimeMethod
umber of mature oocytes. Timepoint: 35-36 hours after high-dose hCG injection. Method of measurement: Transabdominal ultrasound.
© Copyright 2025. All Rights Reserved by MedPath